We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
(+24%)
Cap. Flow
+$1B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$120M |
| 2 |
Globe Life
GL
|
+$115M |
| 3 |
MPT
Medical Properties Trust
MPT
|
+$91.5M |
| 4 |
Arch Capital
ACGL
|
+$69.2M |
| 5 |
Amazon
AMZN
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$138M |
| 2 |
GSK
GSK
|
+$98.7M |
| 3 |
Crown Holdings
CCK
|
+$92.3M |
| 4 |
American Water Works
AWK
|
+$54M |
| 5 |
SolarEdge
SEDG
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Financials | 15.05% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Communication Services | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.4B
| $705K | 0.01% |
24,471
+2,970
| +14% | +$82.9K |
|
|
ZEN
802
DELISTED
ZENDESK INC
ZEN
| $702K | 0.01% |
4,908
+1,363
| +38% | +$169K |
|
803
Invesco Biotechnology & Genome ETF
PBE
$353M
| $701K | 0.01% |
+10,000
| New | +$633K |
|
804
Leidos
LDOS
$17.3B
| $696K | 0.01% |
6,627
+5,042
| +318% | +$483K |
|
805
Vanguard Energy ETF
VDE
$9.84B
| $695K | 0.01% |
13,401
+10,604
| +379% | +$496K |
|
806
Royalty Pharma
RPRX
$25.3B
| $693K | 0.01% |
13,863
+9,339
| +206% | +$396K |
|
807
T. Rowe Price
TROW
$24.3B
| $693K | 0.01% |
4,586
+491
| +12% | +$70.2K |
|
|
PPLT
808
abrdn Physical Platinum Shares ETF
PPLT
$2.04B
| $690K | 0.01% |
68,540
+4,420
| +7% | +$39K |
|
|
WPX
809
DELISTED
WPX Energy, Inc.
WPX
| $683K | 0.01% |
83,895
+1,574
| +2% | +$10K |
|
810
iShares US Medical Devices ETF
IHI
$3.37B
| $681K | 0.01% |
12,492
+1,926
| +18% | +$101K |
|
811
VanEck Low Carbon Energy ETF
SMOG
$134M
| $681K | 0.01% |
4,118
+3,760
| +1,050% | +$509K |
|
812
Mohawk Industries
MHK
$9.22B
| $677K | 0.01% |
4,815
-92
| -2% | -$11.1K |
|
813
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
| $675K | 0.01% |
6,264
-173
| -3% | -$17.6K |
|
|
FPF
814
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.08B
| $674K | 0.01% |
28,043
+2,853
| +11% | +$64K |
|
815
J.M. Smucker
SJM
$12.8B
| $673K | 0.01% |
5,827
+2,695
| +86% | +$313K |
|
816
Yum! Brands
YUM
$41.1B
| $673K | 0.01% |
6,207
+99
| +2% | +$10.1K |
|
817
Healthpeak Properties
DOC
$14.8B
| $666K | 0.01% |
22,052
-1,678
| -7% | -$48.8K |
|
818
Sabesp
SBS
$18.7B
| $663K | 0.01% |
398,666
+148,317
| +59% | +$240K |
|
819
iShares Russell 1000 ETF
IWB
$50.2B
| $662K | 0.01% |
3,132
+1,190
| +61% | +$238K |
|
820
USA Compression Partners
USAC
$3.74B
| $657K | 0.01% |
48,343
+29,412
| +155% | +$338K |
|
|
FL
821
DELISTED
Foot Locker
FL
| $656K | 0.01% |
+16,237
| New | +$633K |
|
822
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.15B
| $656K | 0.01% |
12,872
+15
| +0.1% | +$765 |
|
823
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.22B
| $656K | 0.01% |
45,500
+5,500
| +14% | +$75.1K |
|
824
Welltower
WELL
$171B
| $654K | 0.01% |
10,141
-15
| -0.1% | -$910 |
|
825
Whirlpool
WHR
$2.82B
| $650K | ﹤0.01% |
3,606
-5,700
| -61% | -$1.09M |
|
Similar funds
NAMI
Rockefeller Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.
- Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
- Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
- Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
- Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
- Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
- Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
- Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.
Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.